ELISA: suitable immunofluorescence: suitable immunohistochemistry: suitable western blot: suitable
isotype
IgG1
shipped in
wet ice
Specificity
Specific to HCV NS5A
Immunogen
Recombinant protein to NS5A
Application
ELISA
Immunofluorescence
RIA
Western Blot
Optimal working dilutions must be determined by end user.
Research Category Infectious Diseases
Research Sub Category Infectious Diseases - Viral
This Anti-Hepatitis C Virus Antibody, NS5A is validated for use in ELISA, IF, WB, IH for the detection of Hepatitis C Virus.
Physical form
Format: Purified
Liquid 0.02M PB, 0.25M NaCl, 0.1% sodium azide
Storage and Stability
Store at 2 to 8°C for up to 12 months from date of receipt.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Not finding the right product?
Try our Product Selector Tool.
Storage Class Code
12 - Non Combustible Liquids
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Hepatitis C virus (HCV) is the major cause of progressive liver disease such as chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Previously, we reported that a 29 nucleotide-long 2'-F pyrimidine modified RNA aptamer against the HCV nonstructural protein 5B efficiently inhibited
Hepatitis C Virus (HCV) infection is a major health concern worldwide. The presence of both HCV viral RNA and NS5A proteins in peripheral blood mononuclear cells (PBMCs) indicate the efficacy of the treatment during sustained virological response (SVR) and end
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
